reports
Extendicare Announces Timing of 2024 Third Quarter Results and Confere...
Extendicare Announces Timing of 2024 Third Quarter Results and Conference Call MARKHAM, Ontario, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the third quarter of 2024 after market close on Tuesday, November 12, 2024. A conference call hosted by Michael Guerriere, President and Chief Executive Officer, and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Wednesday, November 13, 2024, at 11:30 a.m. (ET) to discuss the results. To participate i...
Extendicare Announces September 2024 Dividend of C$0.04 per Share
Extendicare Announces September 2024 Dividend of C$0.04 per Share MARKHAM, Ontario, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of September 2024, which is payable on October 15, 2024 to shareholders of record at the close of business on September 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provid...
Extendicare Inc: 1 director
A director at Extendicare Inc sold 183,200 shares at 8.978CAD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
Extendicare Announces 2024 Second Quarter Results
Extendicare Announces 2024 Second Quarter Results MARKHAM, Ontario, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and six months ended June 30, 2024. Second Quarter 2024 Highlights Adjusted EBITDA(1) excluding out-of-period items improved by $19.7 million to $34.5 million, largely driven by rate increases in long-term care (“LTC”) and home health care and volume growth in home health care and managed services.Home health care average daily volume (“ADV”) increased to 30,027, up 10.8% from Q2 2023.LTC a...
Extendicare Announces July 2024 Dividend of C$0.04 per Share
Extendicare Announces July 2024 Dividend of C$0.04 per Share MARKHAM, Ontario, July 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of July 2024, which is payable on August 15, 2024 to shareholders of record at the close of business on July 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care and servic...
Extendicare Announces Timing of 2024 Second Quarter Results and Confer...
Extendicare Announces Timing of 2024 Second Quarter Results and Conference Call MARKHAM, Ontario, July 05, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the second quarter of 2024 after market close on Monday, August 12, 2024. A conference call hosted by Michael Guerriere, President and Chief Executive Officer, and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Tuesday, August 13, 2024, at 11:30 a.m. (ET) to discuss the results. To participate in the...
Extendicare Announces Renewal of Normal Course Issuer Bid
Extendicare Announces Renewal of Normal Course Issuer Bid MARKHAM, Ontario, June 26, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that the Toronto Stock Exchange (the “TSX”) has approved the renewal of Extendicare’s normal course issuer bid (“NCIB”). Under the terms of the NCIB, the Company may purchase for cancellation up to 7,159,997 of its common shares (the “Common Shares”), representing 10% of its public float of issued and outstanding Common Shares. As at June 18, 2024, there were 83,466,978 Common Shares issued and outstandin...
Extendicare Announces June 2024 Dividend of C$0.04 per Share
Extendicare Announces June 2024 Dividend of C$0.04 per Share MARKHAM, Ontario, June 17, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of June 2024, which is payable on July 15, 2024 to shareholders of record at the close of business on June 28, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care and services...
Extendicare Announces Voting Results for its 2024 Annual Meeting of Sh...
Extendicare Announces Voting Results for its 2024 Annual Meeting of Shareholders MARKHAM, Ontario, May 23, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the results of matters voted on at its annual meeting of shareholders held on May 23, 2024 (the “Meeting”). The voting results for each of the matters considered at the Meeting are presented below. The total number of common shares represented by shareholders present in person or by proxy at the Meeting was 31,858,543, representing 38.21% of the Company’s outstanding common shares...
Extendicare Announces 2024 First Quarter Results
Extendicare Announces 2024 First Quarter Results MARKHAM, Ontario, May 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three months ended March 31, 2024. Results are presented in Canadian dollars unless otherwise noted. First Quarter 2024 Highlights Adjusted EBITDA(1) excluding one-time items improved by $8.0 million to $20.3 million, largely driven by home health care volume growth, rate increases and growth in managed services.Home health care growth continued, with Q1 average daily volume (“ADV”) increasing to 2...
Extendicare Announces April 2024 Dividend of C$0.04 per Share
Extendicare Announces April 2024 Dividend of C$0.04 per Share MARKHAM, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of April 2024, which is payable on May 15, 2024 to shareholders of record at the close of business on April 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care and servi...
Extendicare Announces Timing of 2024 First Quarter Results and Confere...
Extendicare Announces Timing of 2024 First Quarter Results and Conference Call MARKHAM, Ontario, April 04, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first quarter of 2024 after market close on Wednesday, May 15, 2024. A conference call hosted by Michael Guerriere, President and Chief Executive Officer and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Thursday, May 16, 2024, at 11:30 a.m. (ET) to discuss the results. To participate in the c...
Extendicare Announces 2023 Fourth Quarter and Year End Results
Extendicare Announces 2023 Fourth Quarter and Year End Results MARKHAM, Ontario, March 07, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and twelve months ended December 31, 2023. Results are presented in Canadian dollars unless otherwise noted. Fourth Quarter 2023 Highlights Adjusted EBITDA(1) increased $19.5 million in Q4 to $28.7 million, driven by home health care volume growth and rate increases; growth in managed services, including full quarter impact of the Revera and Axium transactions; and funding inc...
Extendicare Announces February 2024 Dividend of C$0.04 per Share
Extendicare Announces February 2024 Dividend of C$0.04 per Share MARKHAM, Ontario, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of February 2024, which is payable on March 15, 2024 to shareholders of record at the close of business on February 29, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care...
Extendicare Announces Timing of 2023 Fourth Quarter Results and Confer...
Extendicare Announces Timing of 2023 Fourth Quarter Results and Conference Call MARKHAM, Ontario, Jan. 19, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the fourth quarter of 2023 after market close on Thursday, March 7, 2024. A conference call hosted by Michael Guerriere, President and Chief Executive Officer and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Friday, March 8, 2024, at 11:30 a.m. (ET) to discuss the results. To participate in the con...
Extendicare Announces January 2024 Dividend of C$0.04 per Share
Extendicare Announces January 2024 Dividend of C$0.04 per Share MARKHAM, Ontario, Jan. 15, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of January 2024, which is payable on February 15, 2024 to shareholders of record at the close of business on January 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care...
Extendicare Announces December 2023 Dividend of C$0.04 per Share
Extendicare Announces December 2023 Dividend of C$0.04 per Share MARKHAM, Ontario, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of December 2023, which is payable on January 15, 2024 to shareholders of record at the close of business on December 29, 2023. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of ca...
Extendicare Announces 2023 Third Quarter Results
Extendicare Announces 2023 Third Quarter Results MARKHAM, Ontario, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for the three and nine months ended September 30, 2023. Results are presented in Canadian dollars unless otherwise noted. Third Quarter Highlights Home health care volume growth continued, with Q3 average daily volume (“ADV”) of 27,378, an increase of 1.0% from Q2 2023 and 9.3% from Q3 2022.Long-term care (“LTC”) occupancy continued steady recovery, improving to 97.8%, an increase of 60 bps from Q2 2023 a...
Extendicare Announces October 2023 Dividend of C$0.04 per Share
Extendicare Announces October 2023 Dividend of C$0.04 per Share MARKHAM, Ontario, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of October 2023, which is payable on November 15, 2023 to shareholders of record at the close of business on October 31, 2023. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada). About Extendicare Extendicare is a leading provider of care...
Extendicare Announces Timing of 2023 Third Quarter Results and Confere...
Extendicare Announces Timing of 2023 Third Quarter Results and Conference Call MARKHAM, Ontario, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the third quarter of 2023 after market close on Thursday, November 9, 2023. A conference call hosted by Michael Guerriere, President and Chief Executive Officer and David Bacon, Senior Vice President and Chief Financial Officer, will be held on Friday, November 10, 2023, at 11:30 a.m. (ET) to discuss the results. To participate in th...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.